Supply Chain

Here are six articles published by Becker's Hospital Review this past week highlighting manufacturing issues at Pfizer's drug plant in Kansas, Sen. Bernie Sander's new drug importation bill and more.

A lobby group representing India's largest drugmakers seeks to convince President Donald Trump that lowering drug costs for Americans is more important than bringing drug manufacturing back to the U.S., reports Bloomberg.

President Donald Trump spent a portion of Tuesday night's congressional address speaking about high drug prices. Todd Ebert, president and CEO of the Healthcare Supply Chain Association, on Wednesday issued a statement responding to the president's remarks.

While President Donald Trump repeated his vow to lower drug costs during his first joint address to Congress, he also praised a rare disease drug that costs nearly $300,000 a year, reports Reuters.

Supply chain leaders know the healthcare supply network plays a critical role in hospital operations. But how do other stakeholders view the supply chain? How do leaders know if their supply chain is meeting needs and expectations? And, most importantly,…

The Food and Drug Administration approved Lexicon Pharmaceuticals' drug Xermelo to treat carcinoid syndrome diarrhea.

Royal Philips' ElastQ Imaging device earned market clearance from the Food and Drug Administration.

Sen. Bernie Sanders, I-Vt., on Tuesday introduced a bill that would allow Americans to import cheaper prescription drugs from Canada — as long as they meet specific safety standards, reports The Hill.

Health plans created under the ACA saw prescription drug spending increase at more than three times the rate of commercial health plans and most federal plans in 2016, according to a new report from Express Scripts.

The Food and Drug Administration identified numerous issues with Pfizer's drug manufacturing plant in McPherson, Kan., reports Reuters.